These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24748824)

  • 1. Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults.
    Pleil AM; Darendeliler F; Dörr HG; Hutchinson K; Wollmann HA
    Med Devices (Auckl); 2014; 7():61-71. PubMed ID: 24748824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial.
    Lee JE; Kim SY; Yoo JH; Hwang IT; Lim JS; Yi KH; Rhie YJ; Lee GM; Nam HK; Chae HW; Kim EY; Cheon CK; Lee J; Shim YS; Lee Y; Kim EY; Hwang JS
    Patient Prefer Adherence; 2019; 13():2195-2205. PubMed ID: 31908426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone.
    Pleil AM; Kimel M; McCormack J; Rajicic N; Hey-Hadavi J
    Health Qual Life Outcomes; 2012 Oct; 10():126. PubMed ID: 23046797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.
    Rohrer TR; Winter F; Qvist M; Kappelgaard AM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1603-12. PubMed ID: 24073645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes.
    Wong M; Abdulnabi R; Carey MA; Fu H
    Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.
    Rapaport R; Saenger P; Schmidt H; Hasegawa Y; Colle M; Loche S; Marcantonio S; Bonfig W; Zabransky M; Lifshitz F
    Med Devices (Auckl); 2013; 6():141-6. PubMed ID: 24039458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
    Kivitz A; Cohen S; Dowd JE; Edwards W; Thakker S; Wellborne FR; Renz CL; Segurado OG
    Clin Ther; 2006 Oct; 28(10):1619-29. PubMed ID: 17157117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.
    Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G
    Patient Prefer Adherence; 2014; 8():813-26. PubMed ID: 24940048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA.
    Roszkiewicz J; Swacha Z; Smolewska E
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):64. PubMed ID: 32787934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience and evaluation of reusable insulin pen devices among patients with diabetes in emerging countries.
    Tschiedel B; Almeida O; Redfearn J; Flacke F
    Diabetes Ther; 2014 Dec; 5(2):545-55. PubMed ID: 25213801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.
    Tauber M; Jaquet D; Jesuran-Perelroizen M; Petrus M; Bertrand AM; Coutant R;
    Patient Prefer Adherence; 2013; 7():455-62. PubMed ID: 23737664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
    Demary W; Schwenke H; Rockwitz K; Kästner P; Liebhaber A; Schoo U; Hübner G; Pichlmeier U; Guimbal-Schmolck C; Müller-Ladner U
    Patient Prefer Adherence; 2014; 8():1061-71. PubMed ID: 25125973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
    Matfin G; Van Brunt K; Zimmermann AG; Threlkeld R; Ignaut DA
    J Diabetes Sci Technol; 2015 Apr; 9(5):1071-9. PubMed ID: 25901022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.